Pseudotumor cerebri associated with nalidixic acid.
D002648:Child; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D009268:Nalidixic Acid / Q000009:adverse effects* / Q000627:therapeutic use; D010211:Papilledema / Q000139:chemically induced / Q000150:complications; D011559:Pseudotumor Cerebri / Q000139:chemically induced* / Q000150:complications; D014552:Urinary Tract Infections / Q000188:drug therapy; D014794:Visual Fields
D009268:Nalidixic Acid